Skip to main content
2024 DC-CSEM Conference Main banner
On-Demand

Science

DC2413 - Sustaining Beta Cell function in Diabetes: New developments in screening and treatment approaches

Thursday, November 21, 2024
14:00 - 15:15 AT Time
Location: Argyle A1-2

    Speaker(s)

  • DW

    DIANE K. WHERRETT, MD, FRCPC (she/her/hers)

    Professor, Pediatric Endocrinologist
    Hospital for Sick Children
    Hospital for Sick Children/University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): Canadian Institutes of Health Research (CIHR): Grant/Research Support (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); JDRF Canada: Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing)

  • Ravi Retnakaran, MD

    Professor of Medicine, Clinician-Scientist
    Mount Sinai Hospital
    University of Toronto, Mount Sinai Hospital
    Toronto, Ontario, Canada

    Disclosure(s): Boehringer Ingelheim: Grant/Research Support (Ongoing); Eli Lilly & Company: Consultant (Ongoing); Novo Nordisk: Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing)

    • Moderator(s)

  • AW

    ALANNA WEISMAN, MD, PhD (she/her/hers)

    Clinician Scientist, Assistant Professor
    Division of Endocrinology, Department of Medicine, University of Toronto
    University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): CIHR: Grant/Research Support (Ongoing); CPD Network Association: Committee/Planning Member (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); Diabetes Care community: Speaker/Honoraria (Ongoing); JDRF Canada: Grant/Research Support (Ongoing); MD Briefcase: Speaker/Honoraria (Ongoing); RTOERO: Speaker/Honoraria (Terminated)

Learning Objectives:

  • Understand the Mechanisms of Beta Cell Dysfunction and Preservation in Diabetes: Learn about the underlying biological mechanisms that contribute to beta cell dysfunction in diabetes. Identify the factors that influence beta cell health and survival, including genetic, environmental, and metabolic factors.
  • Evaluate New Screening Methods for Early Detection of Beta Cell Dysfunction: Gain knowledge about the latest advancements in screening technologies and biomarkers for early detection of beta cell dysfunction. Assess the effectiveness and accuracy of various screening approaches in clinical settings.
  • Examine Emerging Treatment Strategies to Sustain Beta Cell Function: Review the current and emerging therapeutic strategies aimed at preserving and enhancing beta cell function in people with diabetes